Stocks360

Kiwa Bio-Tech Products Group Corporation (KWBT)

Stock analysis · OTC · Basic Materials · Agricultural Inputs

Share: Facebook X WhatsApp SMS
$0.00

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
$56.48K
PE (TTM)
-0.00
EPS (TTM)
N/A
Dividend Yield
0.00%
Beta
2.91
Day Range
$0.00 – $0.00
52-wk Range
$0.00 – $0.00
Avg Volume
N/A
Volume
11.03K

Kiwa Bio-Tech Products Group Corporation (KWBT) is a publicly traded company in the Basic Materials sector. Latest price: $0.00. Market cap $56.48K. Trailing PE -0.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Kiwa Bio-Tech Products Group Corporation

Kiwa Bio-Tech Products Group Corporation, along with its various subsidiaries, focuses on the research, production, promotion, and distribution of biotechnological solutions for the agricultural industry, primarily serving the People's Republic of China. The company's core offerings include a diverse range of specialized fertilizers such as biological organic, compound microbial, bio-water soluble, and microbial inoculum types, which are formulated using bacillus species and/or photosynthetic bacteria. Established in 2002, Kiwa Bio-Tech is headquartered in Yangling, China. The firm has also forged significant strategic collaborations with organizations like the Beijing Zhongpin Agricultural Science and Technology Development Center, the China Academy of Agricultural Science's Institute of Agricultural Resources & Regional Planning, and its Institute of Agricultural Economy & Development, as well as Kiwa Bio-Tech (Yangling) Co. Ltd.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)-0.00×
P/S (TTM)0.00×
P/B0.00×
P/FCF (TTM)0.31×
EV / EBITDA-2.99×
EV / Sales0.07×
Earnings Yield-145415.10%
Free Cash Flow Yield324.14%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value$2.94M
Revenue (TTM)$40.09M
Net Income (TTM)-$82.13M
Free Cash Flow (TTM)$5.44M
Net Debt$2.88M
Working Capital$8.58M
Gross Margin23.28%
Operating Margin-2.96%
Net Margin-16.55%
Return on Equity-59.21%
Return on Invested Capital-9.43%

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap